Stevanato Group SpA is an Italy-based manufacturer and distributor engaged in two segments: Biopharmaceutical and Diagnostic Solutions and Engineering, including the production and distribution of drug containment solutions, drug delivery systems, and diagnostic solutions in the pharmaceutical industry. The Company delivers products, processes, and services across all stages of drug developments, including pre-clinical, clinical, and commercialization. Its Engineering segment includes the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology, and diagnostic manufacturing processes. The Company operates locally, in Europe, and globally, including Brazil, China, Mexico, and the United States.
์ข
๋ชฉ ์ฝ๋ STVN
ํ์ฌ ์ด๋ฆStevanato Group SpA
์์ฅ์ผJul 16, 2021
CEOStevanato (Franco)
์ง์ ์5521
์ ํOrdinary Share
ํ๊ณ ์ฐ๋ ์ข
๋ฃJul 16
์ฃผ์Piombino Dese (Pd) Via Molinella, 17
๋์PIOMBINO DESE
์ฆ๊ถ ๊ฑฐ๋์NASDAQ OMX NASDAQ Basic NYSE
๊ตญ๊ฐItaly
์ฐํธ ๋ฒํธ35017
์ ํ390499318173
์น์ฌ์ดํธhttps://www.stevanatogroup.com/
์ข
๋ชฉ ์ฝ๋ STVN
์์ฅ์ผJul 16, 2021
CEOStevanato (Franco)
์ง๋ 5๋
๋์ ์ด
53.45M
USD์ ๋ฐฐ๋น๊ธ์ด ๋ถ๋ฐฐ๋์์ต๋๋ค.
STVN.NB Final Cash Dividend of gross EUR 0.054 paid on Jul 17, 2025 going ex on Jun 05, 2025
STVN.NB Final Cash Dividend of gross EUR 0.053 paid on Jul 15, 2024 going ex on Jun 04, 2024
STVN.NB Final Cash Dividend of gross EUR 0.054 paid on Jul 17, 2023 going ex on Jun 07, 2023
STVN.NB Final Cash Dividend of gross EUR 0.051 paid on Jul 13, 2022 going ex on Jun 13, 2022